17554481

Source:http://linkedlifedata.com/resource/pubmed/id/17554481

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012634, umls-concept:C0087111, umls-concept:C0241886, umls-concept:C0666743, umls-concept:C1280464, umls-concept:C1299003
pubmed:issue	3
pubmed:dateCreated	2007-6-7
pubmed:abstractText	To assess the efficacy and safety of infliximab in the treatment of sight-threatening uveitis and extraocular manifestations in patients with Behçet's disease.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0044652
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:issn	0021-5155
pubmed:author	pubmed-author:AccorintiMassimoM, pubmed-author:ContiFabrizioF, pubmed-author:ParoliMaria PiaMP, pubmed-author:PirragliaMaria PiaMP, pubmed-author:Pivetti-PezziPaolaP, pubmed-author:PrioriRobertaR
pubmed:copyrightInfo	Copyright (c) Japanese Ophthalmological Society 2007.
pubmed:issnType	Print
pubmed:volume	51
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	191-6
pubmed:meshHeading	pubmed-meshheading:17554481-Adult, pubmed-meshheading:17554481-Anti-Inflammatory Agents, pubmed-meshheading:17554481-Antibodies, Monoclonal, pubmed-meshheading:17554481-Behcet Syndrome, pubmed-meshheading:17554481-C-Reactive Protein, pubmed-meshheading:17554481-Dose-Response Relationship, Drug, pubmed-meshheading:17554481-Drug Therapy, Combination, pubmed-meshheading:17554481-Female, pubmed-meshheading:17554481-Follow-Up Studies, pubmed-meshheading:17554481-Glucocorticoids, pubmed-meshheading:17554481-Humans, pubmed-meshheading:17554481-Immunosuppressive Agents, pubmed-meshheading:17554481-Male, pubmed-meshheading:17554481-Middle Aged, pubmed-meshheading:17554481-Prednisone, pubmed-meshheading:17554481-Recurrence, pubmed-meshheading:17554481-Time Factors, pubmed-meshheading:17554481-Treatment Outcome, pubmed-meshheading:17554481-Tumor Necrosis Factor-alpha
pubmed:articleTitle	Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
pubmed:affiliation	Servizio di Immunovirologia Oculare, Dipartimento di Scienze Oftalmologiche, Università degli Studi di Roma La Sapienza, Rome, Italy.
pubmed:publicationType	Journal Article